docetaxel

You have access
Systematic Trial for Evaluating Docetaxel in a Human Prostate Cancer Cell DU145 Xenograft Model
MIYUKI MABUCHI, MASAHIRO UEDA, YURI YOSHIDA, KOTA HORIIKE, KENTA YAMAOKA, SYUHEI NAKAO, TADASHI SHIMIZU, YUKO UEDA, KAZUTAKE TSUJIKAWA and AKITO TANAKA

Anticancer Research April 2017, 37 (4) 1665-1676;
You have access
The Clinical Efficacy of Enzalutamide in Metastatic Prostate Cancer: Prospective Single-center Study
GIUSEPPE CICERO, ROSSELLA DE LUCA, PATRIZIA DORANGRICCHIA and FRANCESCO DIELI

Anticancer Research March 2017, 37 (3) 1475-1480;
You have access
Second-line Erlotinib or Intermittent Erlotinib plus Docetaxel in Male Ex-smokers with Squamous NSCLC: The TALISMAN Randomized Trial
CESARE GRIDELLI, ANTONIO CHELLA, GIUSEPPE VALMADRE, GIACOMO ALLEGRINI, MATTEO BRIGHENTI, PAOLO BIDOLI, ANTONIO ROSSI, PAOLO MAIONE, MARIA RITA MIGLIORINO, SERENA RICCIARDI and FILIPPO DE MARINIS

Anticancer Research December 2016, 36 (12) 6535-6540;
You have access
Safety and Anti-tumor Effects of Docetaxel Plus Cisplatin in Intermediate- and High-risk Endometrial Cancer
DAISUKE MIYAHARA, TAKAHIRO KATSUTA, MIYAKO MAEHARA, YOKO TAKAHASHI, SATOSHI FUKAGAWA, KOUHEI MIYATA, CHIHIRO KIYOSHIMA, FUSANORI YOTSUMOTO, HARUCHIKA ANAN and SHINGO MIYAMOTO

Anticancer Research July 2016, 36 (7) 3725-3729;
You have access
Retrospective Analysis on the Feasibility and Efficacy of Docetaxel–Cisplatin Therapy for Recurrent Endometrial Cancer
TOMOMI NINOMIYA, WATARU YAMAGAMI, NOBUYUKI SUSUMU, TAKESHI MAKABE, KENSUKE SAKAI, MICHIKO WADA, AYA TAKIGAWA, TATSUYUKI CHIYODA, HIROYUKI NOMURA, FUMIO KATAOKA, AKIRA HIRASAWA, KOUJI BANNO and DAISUKE AOKI

Anticancer Research April 2016, 36 (4) 1751-1758;
You have access
Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer
SHINSUKE KANEKIYO, SHIGERU TAKEDA, MASAO NAKAJIMA, MITSUO NISHIYAMA, MASAHIRO KITAHARA, YOSHITARO SHINDOU, IIDA MICHIHISA, TOSHIHIRO ABE, SHIGEFUMI YOSHINO, SHOICHI HAZAMA and HIROAKI NAGANO

Anticancer Research April 2016, 36 (4) 1923-1927;
You have access
Early Response of Esophageal Cancer to Neoadjuvant Chemotherapy with Docetaxel–Cisplatin–5-Fluorouracil Represents Sensitivity: A Phase II Study
AKIRA MATSUMOTO, KATSUNORI NISHIKAWA, MASAMI YUDA, YUJIRO TANAKA, YUICHIRO TANISHIMA, YASUHIRO ARAKAWA, YOSHIO ISHIBASHI, TOSHIKAZU SAKUYAMA, NOBUO OMURA, NORIO MITSUMORI, KEISUKE AIBA and KATSUHIKO YANAGA

Anticancer Research April 2016, 36 (4) 1937-1942;
You have access
Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local or Metastatic Esophageal Cancer
KENICHI IWASAKI, YOSHIAKI OSAKA, SHINGO TACHIBANA, TAKESHI SUDA, YOSHIHIRO OTA, SUMITO HOSHINO and AKIHIKO TSUCHIDA

Anticancer Research March 2016, 36 (3) 987-994;
You have access
Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus
TOSHIYASU OJIMA, MIKIHITO NAKAMORI, MASAKI NAKAMURA, MASAHIRO KATSUDA, KEIJI HAYATA, TOMOYA KATO, JUNYA KITADANI, HIROTAKA TABATA, AKIHIRO TAKEUCHI, MAKOTO IWAHASHI and HIROKI YAMAUE

Anticancer Research February 2016, 36 (2) 829-834;
You have access
Effects of Cabazitaxel in Renal Cell Carcinoma Cell Lines
KOSUKE MIZUTANI, MASASHI TOMODA, YUTA OHNO, HIDEKI HAYASHI, YASUNORI FUJITA, KYOJIRO KAWAKAMI, KOJI KAMEYAMA, TAKU KATO, TADASHI SUGIYAMA, YOSHINORI ITOH, MASAFUMI ITO and TAKASHI DEGUCHI

Anticancer Research December 2015, 35 (12) 6671-6677;

Main menu

User menu

Search

docetaxel

Pages